Key takeaways
✔ An international team of researchers proposes rethinking longevity research by starting before birth rather than only in adulthood.
✔ The proposed consortium is called PROSPER (Pregestational and Pediatric Research for Optimal Healthspan and Early-life Resilience).
✔ The researchers introduce a new concept, peakspan, the period of life when a person performs at their highest physical and cognitive level.
✔ Published in Nature Health, the proposal is still in its early stages. It is a position paper, not a clinical protocol.
What if longevity research has been starting too late? That is the question raised by an international team of researchers in a correspondence article published in Nature Health in 2026. Their argument is that most healthy aging research focuses on adults, after decades of biological changes have already occurred. Instead, they propose a new research framework that begins during pregnancy. Here’s what you need to know.
Why do researchers want to rethink where longevity research begins?
Healthy longevity medicine aims to translate discoveries from biogerontology into clinical practice. Until now, it has focused almost exclusively on adults, with interventions introduced only after decades of accumulated age-related molecular and cellular changes.
According to the authors, this approach overlooks a critical window of opportunity, the earliest stages of life, even before birth.
Previous studies have already explored childhood factors associated with future longevity. However, the researchers behind PROSPER argue that what is currently missing is a coherent framework for evaluating aging across the entire lifespan.
One practical example concerns biological age markers. Biomarkers used to assess aging in adults cannot simply be applied to children because they do not carry the same biological meaning during development. Addressing these inconsistencies is one of the main goals of the proposed consortium.
Level of evidence
This is a correspondence article, meaning it represents a reasoned position by a group of researchers rather than a clinical trial with measured outcomes. The proposal still needs to be discussed and validated by the broader scientific community.
What is the PROSPER consortium?
PROSPER stands for Pregestational and Pediatric Research for Optimal Healthspan and Early-life Resilience.
The consortium aims to combine multi-omics data, including genetic, molecular, and cellular information, with clinical observations and functional measurements collected throughout different stages of development. The goal is to build biological trajectories that could help predict future health risks and guide interventions from the earliest stages of life.
Ultimately, the researchers envision integrating these diagnostic tools and therapeutic approaches into routine obstetric and pediatric care. Such a shift would move longevity medicine away from a reactive model focused on disease management toward a proactive approach that optimizes health across the life course.
| Current approach | Proposed approach (PROSPER) | |
|---|---|---|
| Population studied | Primarily adults | From pregnancy and throughout childhood |
| Type of intervention | Reactive, after decades of accumulated biological changes | Proactive, beginning in early life |
| Biomarkers used | Adult biomarkers | Age-specific biomarkers yet to be developed |
| Clinical integration | Limited connection with pediatric care | Integrated into routine obstetric and pediatric care |
“Peakspan”, a new way to think about aging
The researchers behind PROSPER also highlight a relatively new concept called peakspan.
Peakspan refers to the period of life when a person reaches their highest level of physical and cognitive performance, a stage everyone experiences, although most people only recognize it in hindsight.
Rather than focusing solely on total lifespan or years lived in good health, the concept encourages researchers to also consider how much of life is spent at peak performance.
Three concepts not to confuse
Lifespan: The total number of years lived.
Healthspan: The number of years lived in good health, without major disease or disability.
Peakspan: The period of life during which an individual reaches their highest physical and cognitive performance.
What could this change in practice?
If this approach were eventually adopted, longevity monitoring could become part of routine healthcare beginning during pregnancy, using diagnostic tools tailored to each developmental stage.
The authors emphasize, however, that this remains a long-term vision. No clinical protocol is currently available, and the proposal intentionally remains broad while bringing together disciplines that have historically worked separately, including obstetrics, pediatrics, and biogerontology.
The limitations of this proposal
It is important to emphasize that PROSPER is currently only a proposal developed by a group of longevity researchers, not an established scientific consensus.
The published article provides few details about practical implementation. There is currently no timeline and no clinical trial protocol. Its success will largely depend on the ability to foster collaboration between medical specialties that have traditionally operated independently.
FAQ
What is the PROSPER consortium?
PROSPER is a proposed international research consortium that aims to study healthy longevity starting during pregnancy and childhood rather than focusing only on adulthood.
What is “peakspan”?
Peakspan is the period of life during which a person reaches their highest level of physical and cognitive performance.
Does longevity research already study children?
Some studies have already examined childhood factors associated with future longevity. However, the researchers behind PROSPER argue that a coherent life-course framework connecting all stages of development is still lacking.
Can we already take action during pregnancy to increase longevity?
Not yet. There are currently no validated clinical protocols. The PROSPER proposal is still at an early stage and does not provide immediate clinical recommendations.
What stage has the project reached?
The proposal was introduced in a correspondence article published in 2026. It now needs to be discussed and evaluated by the scientific community before any implementation.
What is the difference between lifespan, healthspan, and peakspan?
Lifespan refers to total years lived. Healthspan is the number of years lived in good health. Peakspan is the period of life during which an individual performs at their highest physical and cognitive level.
Sources
- Strauss et al., A Life-Course Consortium for Healthy Longevity Medicine, Nature Health, 2026.
- PNAS study cited by the authors on childhood factors associated with future longevity.
- Aging and Disease, 2026, article introducing the concept of peakspan.
- ScienceAlert, coverage of the correspondence article (July 2026).
Methodology
The information presented in this article is based on a scientific correspondence published in the peer-reviewed journal Nature Health, together with the studies cited by its authors.
This is not a clinical trial but rather a proposal for a new research framework, as reflected in the evidence rating above.
Disclaimer
This article is provided for informational purposes only and should not be considered a substitute for personalized medical advice.
Continue exploring longevity
Explore this longevity topic
